cardiotomskСибирский журнал клинической и экспериментальной медициныSiberian Journal of Clinical and Experimental Medicine2713-29272713-265XTSU publishing10.29001/2073-8552-2021-36-3-23-26cardiotomsk-1237Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESРоль микронутриентов в реабилитации пациентов после острого нарушения мозгового кровообращенияThe role of micronutrients in the rehabilitation of patients after acute cerebrovascular accidenthttps://orcid.org/0000-0002-3492-1778ЗалетоваТ. С.ZaletovaT. S.

Залетова Татьяна Сергеевна - научный сотрудник, отделение персонализированной диетотерапии.

109240, Москва, Устьинский проезд, 2/14

Tatyana S. Zaletova, Research Scientist, Personalized Diet Therapy Department.

2/14, Ustinsky pas., Moscow, 109240

tatyana.zaletova@ya.ruhttps://orcid.org/0000-0002-4367-2232ЗайнудиновЗ. М.ZainudinovZ. M.

Зайнудинов Зайнудин Мусаевич - доктор медицинских наук, главный врач клиники.

109240, Москва, Устьинский проезд, 2/14

Zainudin M. Zainudinov, Dr. Sci. (Med.), Chief Physician of Clinic.

2/14, Ustinsky pas., Moscow, 109240

zain_z@mail.ruФедеральный исследовательский центр питания, биотехнологии и безопасности пищиРоссияFederal Research Center for Nutrition, Biotechnology, and Food SafetyRussian Federation2021061020213632326Copyright © Залетова Т.С., Зайнудинов З.М., 20212021Залетова Т.С., Зайнудинов З.М.Zaletova T.S., Zainudinov Z.M.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.sibjcem.ru/jour/article/view/1237

Широкое применение витаминных и минеральных добавок может улучшить результаты реабилитации пациентов, перенесших острое нарушение мозгового кровообращения (ОНМК). В этом аспекте самые убедительные доказательства существуют для витаминов С и Е, калия, магния. Индивидуальное диетологическое консультирование также показало положительные результаты.

The broad benefits of vitamin and mineral supplementation can improve rehabilitation outcomes in patients with stroke. In this aspect, the most compelling evidence exists for vitamin C, vitamin E, potassium, and magnesium. Individualized nutritional counseling was also associated with positive outcomes.

питаниеострое нарушение мозгового кровообращенияпрофилактикадиетологияnutritionacute cerebrovascular accidentpreventiondietologyработа выполнена в рамках фундаментального исследования по теме № 0529-2019-006the work was done in a framework of fundamental study topic No. 0529-2019-006ReferencesWorld Health Organisation The Top 10 Causes of Death. 2014. URL: http://www.who.int/mediacentre/factsheets/fs310/en/ (available 03.12.2016).World Health Organisation The Top 10 Causes of Death. 2014. URL: http://www.who.int/mediacentre/factsheets/fs310/en/ (available 03.12.2016).Ишемический инсульт и транзиторная ишемическая атака у взрослых: клинические рекомендации. М.; 2020:208.Ischemic stroke and transient ischemic attack in adults: Сlinical guideline. Мoscow; 2020:208 (In Russ.).Gomes F., Emery P.W., Weekes C.E. Risk of malnutrition is an independent predictor of mortality, length of hospital stay, and hospitalization costs in stroke patients. J. Stroke Cerebrovasc. Dis. 2016;25(4):799– 806. DOI: 10.1016/j.jstrokecerebrovasdis.2015.12.017.Gomes F., Emery P.W., Weekes C.E. Risk of malnutrition is an independent predictor of mortality, length of hospital stay, and hospitalization costs in stroke patients. J. Stroke Cerebrovasc. Dis. 2016;25(4):799– 806. DOI: 10.1016/j.jstrokecerebrovasdis.2015.12.017.Aquilani R., Sessarego P., Iadarola P., Barbieri A., Boschi F. Nutrition for brain recovery after ischemic stroke: An added value to rehabilitation. Nutr. Clin. Pract. 2011;26(3):339–345. DOI: 10.1177/0884533611405793.Aquilani R., Sessarego P., Iadarola P., Barbieri A., Boschi F. Nutrition for brain recovery after ischemic stroke: An added value to rehabilitation. Nutr. Clin. Pract. 2011;26(3):339–345. DOI: 10.1177/0884533611405793.Jenkins D.J.A., Spence J.D., Giovannucci E.L., Kim Y.I., Josse R., Vieth R. et al. Supplemental vitamins and minerals for CVD prevention and treatment. J. Am. Coll. Cardiol. 2018;71(22):2570–2584. DOI: 10.1016/j.jacc.2018.04.020.Jenkins D.J.A., Spence J.D., Giovannucci E.L., Kim Y.I., Josse R., Vieth R. et al. Supplemental vitamins and minerals for CVD prevention and treatment. J. Am. Coll. Cardiol. 2018;71(22):2570–2584. DOI: 10.1016/j.jacc.2018.04.020.Almeida O.P., Marsh K., Alfonso H., Flicker L., Davis T.M.E., Hankey G.J. B-vitamins reduce the long-term risk of depression after stroke: The VITATOPS-DEP Trial. Ann. Neurol. 2010;68(4):503–510. DOI: 10.1002/ana.22189.Almeida O.P., Marsh K., Alfonso H., Flicker L., Davis T.M.E., Hankey G.J. B-vitamins reduce the long-term risk of depression after stroke: The VITATOPS-DEP Trial. Ann. Neurol. 2010;68(4):503–510. DOI: 10.1002/ana.22189.Pan W.-H., Lai Y.-H., Yeh W.-T., Chen J.-R., Jeng J.-S., Bai C.-H. et al. Intake of potassiumand magnesium-enriched salt improves function al outcome after stroke: A randomized, multicenter, double-blind controlled trial. Am. J. Clin. Nutr. 2017;106(5):1267–1273. DOI: 10.3945/ajcn.116.148536.Pan W.-H., Lai Y.-H., Yeh W.-T., Chen J.-R., Jeng J.-S., Bai C.-H. et al. Intake of potassiumand magnesium-enriched salt improves function al outcome after stroke: A randomized, multicenter, double-blind controlled trial. Am. J. Clin. Nutr. 2017;106(5):1267–1273. DOI: 10.3945/ajcn.116.148536.Sahota P., Savitz S.I. Investigational therapies for ischemic stroke: Neuroprotection and neurorecovery. Neurotherapeutics. 2011;8(3):434–451. DOI: 10.1007/s13311-011-0040-6.Sahota P., Savitz S.I. Investigational therapies for ischemic stroke: Neuroprotection and neurorecovery. Neurotherapeutics. 2011;8(3):434–451. DOI: 10.1007/s13311-011-0040-6.Sutherland B.A., Minnerup J., Balami J.S., Arba F., Buchan A.M., Kleinschnitz C. Neuroprotection for ischaemic stroke: Translation from the bench to the bedside. Int. J. Stroke. 2012;7(5):407–418. DOI: 10.1111/j.1747-4949.2012.00770.x.Sutherland B.A., Minnerup J., Balami J.S., Arba F., Buchan A.M., Kleinschnitz C. Neuroprotection for ischaemic stroke: Translation from the bench to the bedside. Int. J. Stroke. 2012;7(5):407–418. DOI: 10.1111/j.1747-4949.2012.00770.x.Degan D., Ornello R., Tiseo C., Carolei A., Sacco S., Pistoia F. The role of inflammation in neurological disorders. Curr. Pharm. Des. 2018;24(14):1485–1501. DOI: 10.2174/1381612824666180327170632.Degan D., Ornello R., Tiseo C., Carolei A., Sacco S., Pistoia F. The role of inflammation in neurological disorders. Curr. Pharm. Des. 2018;24(14):1485–1501. DOI: 10.2174/1381612824666180327170632.Wu X., Schauss A.G. Mitigation of Inflammation with Foods. J. Agric. Food Chem. 2012;60(27):6703–6717. DOI: 10.1021/jf3007008.Wu X., Schauss A.G. Mitigation of Inflammation with Foods. J. Agric. Food Chem. 2012;60(27):6703–6717. DOI: 10.1021/jf3007008.D’Elia L., Iannotta C., Sabino P., Ippolito R. Potassium-rich diet and risk of stroke: Updated meta-analysis. Nutr. Metab. Cardiovasc. Dis. 2014;24(6):585–587. DOI: 10.1016/j.numecd.2014.03.001.D’Elia L., Iannotta C., Sabino P., Ippolito R. Potassium-rich diet and risk of stroke: Updated meta-analysis. Nutr. Metab. Cardiovasc. Dis. 2014;24(6):585–587. DOI: 10.1016/j.numecd.2014.03.001.Gillham S., Endacott R. Impact of enhanced secondary preven tion on health behaviour in patients following minor stroke and transient ischaemic attack: A randomized controlled trial. Clin. Rehabil. 2010;24(9):822–830. DOI: 10.1177/0269215510367970.Gillham S., Endacott R. Impact of enhanced secondary preven tion on health behaviour in patients following minor stroke and transient ischaemic attack: A randomized controlled trial. Clin. Rehabil. 2010;24(9):822–830. DOI: 10.1177/0269215510367970.Ovbiagele B., Saver J.L., Fredieu A., Suzuki S., Selco S., Rajajee V. et al In-hospital initiation of secondary stroke prevention therapies yields high rates of adherence at follow-up. Stroke. 2004;35(12):2879–2883. DOI: 10.1161/01.STR.0000147967.49567.d6.Ovbiagele B., Saver J.L., Fredieu A., Suzuki S., Selco S., Rajajee V. et al In-hospital initiation of secondary stroke prevention therapies yields high rates of adherence at follow-up. Stroke. 2004;35(12):2879–2883. DOI: 10.1161/01.STR.0000147967.49567.d6.Brouwer-Goossensen D., van Genugten L., Lingsma H., Dippel D., Koudstaal P., den Hertog H. Determinants of intention to change health-related behavior and actual change in patients with TIA or mi nor ischemic stroke. Patient Educ. Couns. 2016;99(4):644–650. DOI: 10.1016/j.pec.2015.10.028.Brouwer-Goossensen D., van Genugten L., Lingsma H., Dippel D., Koudstaal P., den Hertog H. Determinants of intention to change health-related behavior and actual change in patients with TIA or mi nor ischemic stroke. Patient Educ. Couns. 2016;99(4):644–650. DOI: 10.1016/j.pec.2015.10.028.

The authors declare that there are no conflicts of interest present.